Filing Details

Accession Number:
0001144204-18-052768
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-05 16:34:07
Reporting Period:
2018-10-03
Accepted Time:
2018-10-05 16:34:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1479419 Kala Pharmaceuticals Inc. KALA Pharmaceutical Preparations (2834) 270604595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619841 M. Rajeev Shah C/O Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-03 2,424,242 $8.25 4,537,478 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Footnotes
  1. Includes (a) 2,000,301 shares of Common Stock that are held by RA Capital Healthcare Fund, L.P.(the "Fund") and (b) 423,941 shares of Common Stock that are held in an account owned by a separately managed account (the "Account").
  2. Following the reported transaction, the Fund held 3,727,401 shares and the Account held 810,077 shares.
  3. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser, and Mr. Shah is a managing director of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein.